Partner Content Partner Content Digital health fosters new ecosystems - start-up investment ... Healthcare stakeholders work together
Views & Analysis Biotech in post-Brexit Britain: the future for the UK’s phar... Drug development can be quite a risky business at the best of times, but particularly in the biotech sector where companies may only have a few assets to their name.
News Grey Wolf raises £10m for tumour 'illumination' tech Immuno-oncology biotech Grey Wolf Therapeutics has raised £10 million in series A financing to develop therapies that increase tumour visibility.
News 2018 breaks records for digital health investment: report Global funding in digital health companies reached new highs last year as $9.5 billion was raised in 698 deals, according to a new report.
News Novo Holdings invests in three more AMR biotechs Novo Holdings’ REPAIR Impact Fund, which helps fund companies tackling antimicrobial resistance (AMR), has announced three new investments.
Views & Analysis JP Morgan Healthcare: where science, tech and finance collid... Welcome to 2019! Hopefully by now you’re managing to ease yourself back into things, no doubt with good intentions for the year ahead.
News AZ's gMG drug Klygefa nears EU approval AstraZeneca's generalised myasthenia gravis (gMG) therapy Klygefa gets CHMP recommendation, alongside several other novel medicines.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
